A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making.

A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making.

BACKGROUND:Venous thromboembolism (VTE) is a major global cause of morbidity and mortality. Low molecular weight heparin (LMWH) and fondaparinux (FDP) are frequently used to treat and prevent VTE and have a variety of safety and practical advantages over other anticoagulants, including use in outpat...

Full description

Bibliographic Details
Main Authors: Amy Johnston, Shu-Ching Hsieh, Marc Carrier, Shannon E Kelly, Zemin Bai, Becky Skidmore, George A Wells
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6226206?pdf=render

Internet

http://europepmc.org/articles/PMC6226206?pdf=render

Similar Items